Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;28(5):340–348. [Article in Spanish] doi: 10.1016/S0212-6567(01)70386-1

Impacto y aplicabilidad del sistema de precios de referencia☆

JL Segú Tolsà a, C Zara Yahn b
PMCID: PMC7688813  PMID: 11602105

The content is available as a PDF (115.8 KB).

Footnotes

☆

Este trabajo ha sido parcialmente reproducido del encargo solicitado por la Fundación Institut Borja de Bioética.

Bibliografía

  • 1.Segú L., Solans P., Gavilán P., Vargas I., Ruiz B., Manté C. La utilització de medicaments; la perspectiva dels proveïdors. Fulls Económics del Sistema Sanitari. 1999;33:18–23. [Google Scholar]
  • 2.Lobo F. La regulación de los servicios sanitarios en España. Biblioteca Civitas Economía y Empresa, Colección Economía; Madrid: 1997. La creación de un mercado de medicamentos genéricos en España; pp. 393–430. [Google Scholar]
  • 3.El sector farmacéutico en Alemania . Oficina de Economía de la Salud. Farmaindustria; Madrid: 1996. Las reformas sanitarias y su impacto en la industria farmacéutica. [Google Scholar]
  • 4.Le Pen C. European drugs prices: old and new models. Preliminary version.
  • 5.Munnich F.E., Sullivan K. The impact of the recent legislative change in Germany. Pharmacoeconomics. 1994;6(Supl 1):22–27. doi: 10.2165/00019053-199400061-00008. [DOI] [PubMed] [Google Scholar]
  • 6.Zweiffel P., Crivelli L. Price regulation of drugs: lessons from Germany. J Regul Econ. 1996;10:257–273. [Google Scholar]
  • 7.Rigter H. Recent public policies in the Netherlands to control pharmaceutical pricing and reimbursement. Pharmacoeconomics. 1994;6(Supl 1):15–21. doi: 10.2165/00019053-199400061-00007. [DOI] [PubMed] [Google Scholar]
  • 8.Cornelis M. The 1996 pricing and reimbursement policy in the Netherlands. Pharmacoeconomics. 1996;10(Supl 2):75–80. doi: 10.2165/00019053-199600102-00012. [DOI] [PubMed] [Google Scholar]
  • 9.Clausen J. Financing of prescription drugs in Denmark: alternative designs of the reimbursement system. Poster presented at the Third European Conference on Health Economics; Stocolmo, Suecia, 20–22; agosto de 1995. [Google Scholar]
  • 10.Jönsson B. Cost sharing for pharmaceuticals: the Swedish reimbursement system. Pharmacoeconomics. 1996;10(Supl 2):68–74. doi: 10.2165/00019053-199600102-00011. [DOI] [PubMed] [Google Scholar]
  • 11.Jönsson B. Pricing and reimbursement of pharmaceuticals in Sweden. Pharmacoeconomics. 1994;6(Supl 1):51–60. doi: 10.2165/00019053-199400061-00013. [DOI] [PubMed] [Google Scholar]
  • 12.López G., Puig J. Review of the literature on reference pricing. Health Policy. 2000;54:87–123. doi: 10.1016/s0168-8510(00)00100-7. [DOI] [PubMed] [Google Scholar]
  • 13.Freemantle N., Bloor K. Leassons from international experience in controlling pharmaceutical expenditure I: Influencing patients. BMJ. 1996;312:1469–1471. doi: 10.1136/bmj.312.7044.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Freemantle N., Bloor K. Leassons from international experience in controlling pharmaceutical expenditure II: Influencing doctors. BMJ. 1996;312:1525–1527. doi: 10.1136/bmj.312.7045.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Freemantle N., Bloor K. Leassons from international experience in controlling pharmaceutical expenditure III: Regulating Industry. BMJ. 1996;313:33–35. doi: 10.1136/bmj.313.7048.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dickson M., Redwood H. Pharmaceutical reference prices. How do they work in prectice? Pharmacoeconomics. 1998;14:471–479. doi: 10.2165/00019053-199814050-00002. [DOI] [PubMed] [Google Scholar]
  • 17.Ulrich V., Wille E. Healthcare reform and expenditure on drugs: the German situation. Pharmacoeconomics. 1996;10(Supl 2):81–88. doi: 10.2165/00019053-199600102-00013. [DOI] [PubMed] [Google Scholar]
  • 18.Schoffski O. Consequences of implementing a drug budget for office-based physicians in Germany. Pharmacoeconomics. 1996;10(Supl 2):37–47. doi: 10.2165/00019053-199600102-00007. [DOI] [PubMed] [Google Scholar]
  • 19.Narine L., Senathirajah M., Smith T. Evaluating reference-based pricing: initial findings and prospects. CMAJ. 1999;161:286–288. [PMC free article] [PubMed] [Google Scholar]
  • 20.Cueni T. An industrial policy for the pharmaceutical industry in Europe. The way forward, in health care reforms and the role of the pharmaceutical industry; Proceedings of a European Workshop, 16–17; septiembre de 1994. Hertfordshire, Reino Unido. [Google Scholar]
  • 21.Muñio S. Influencia de los precios de referencia en la industria farmacéutica. Farma Forum 2000. III Encuentro del Sector Farmacéutico Español; Barcelona; febrero de 2000. [Google Scholar]
  • 22.Segú L., Zara C. El sistema de preus de referència com a mecanisme de regulació del mercat farmacèutic: descripció, impactes i aplicabilitat a Espanya. Bioètica i Debat Monogràfic. 1997; oct:1–32. [Google Scholar]
  • 23.Plaza F. Precios de referencia, 22.000 millones de ahorro anual. El Global. 2000;10:4. [Google Scholar]
  • 24.Baines D.L., Whynes D.K., Tolley K.H. General practitioner fundholding and prescribing expenditure control: evidence from a rural english health authority. Pharmacoeconomics. 1997;11:350–358. doi: 10.2165/00019053-199711040-00006. [DOI] [PubMed] [Google Scholar]
  • 25.Towse A. The pricing and reimbursement of pharmaceuticals. Pharmacoeconomics. 1994;6(Supl 1):36–38. doi: 10.2165/00019053-199400061-00010. [DOI] [PubMed] [Google Scholar]
  • 26.Bosanquet N., Zammit-Lucia J. The effect of competition on drug prices. Pharmacoeconomics. 1995;8:473–478. doi: 10.2165/00019053-199508060-00003. [DOI] [PubMed] [Google Scholar]
  • 27.Maling T.J.B. The New Zeland preferred medicins concept: a national scheme for audit and quality assurance prescribing. Pharmacoeconomics. 1994;6:5–14. doi: 10.2165/00019053-199406010-00002. [DOI] [PubMed] [Google Scholar]
  • 28.Stewart-Brown S., Surender R., Bradlow J., Coulter A., Doll H. The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme. BMJ. 1995;311:1543–1547. doi: 10.1136/bmj.311.7019.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zara C., Segú J.L., Font M., Rovira J. La regulación de los medicamentos: teoría y práctica. Gaceta Sanitaria. 1998;12:39–49. doi: 10.1016/s0213-9111(98)76441-6. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES